CompoAtlas

Artrex Tablets

Artrex Tablets, licence 80079458: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Other names
Artrex DS
Licence holder
Bioved Pharmaceuticals, Inc
NPN or DIN-HM
80079458
Status
Active licence
Licence date
15 August 2017
Revision date
21 May 2019
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Withania somnifera

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 5.0:1.0

Dry plant equivalent : 900.0 mg

Potency : 1.5 % Withanolides

180.0 mgNot calculated
Boswellia serrata

Source : Boswellia serrata - Oléorésine (écorce de tronc)

Extract : Matériel brut sec

Extraction ratio : 3.5:1.0

Dry plant equivalent : 630.0 mg

Potency : 60.0 % Boswellic acids

180.0 mgNot calculated
Zingiber officinale

Source : Rhizome

Extract : Matériel brut sec

Extraction ratio : 6.0:1.0

Dry plant equivalent : 288.0 mg

48.0 mgNot calculated
Curcuma longa

Source : Rhizome

Extract : Matériel brut sec

Extraction ratio : 12.0:1.0

Dry plant equivalent : 432.0 mg

36.0 mgNot calculated

Non-medicinal ingredients

Phosphate dicalcique, Dioxyde de silicium, Stéarate de magnésium, Gomme de cellulose, Acide stéarique, Polacriline potassium

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 1.0 Comprimé ; maximum: 2.0 Comprimé2.0 Jour(s)

Uses authorised in Canada

Text supplied in English because no French text is available.

Provides antioxidants for the maintenance of good health. Turmeric is (traditionally) used in Herbal Medicine as an anti-inflammatory to help relieve joint pain. Ashwagandha is traditionally used in Ayurveda as Rasayana (rejuvenative tonic). Ashwagandha is traditionally used in Ayurveda to balance aggravated Vata (nervine tonic, sedative).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80079458

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2019. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

List recorded in 2019. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line